Profile: DiaSorin SpA (DIAS.MI)

DIAS.MI on Milan Stock Exchange

29.40EUR
16 Apr 2014
Price Change (% chg)

€0.18 (+0.62%)
Prev Close
€29.22
Open
€29.19
Day's High
€29.65
Day's Low
€29.19
Volume
816
Avg. Vol
108,651
52-wk High
€39.22
52-wk Low
€26.62

Search Stocks
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis.

Company Address

DiaSorin SpA

via Crescentino snc
SALUGGIA     13040
P: +390161.487526
F: +390161.487670

Search Stocks